Caroline Pavis, Director of Global Communications, Animas Corporation
I recently joined Animas as the new director of global communications. For those of you who may not know, Animas is a company within the Johnson & Johnson family of companies with a direct-to-patient selling model. Many of our 500 employees worldwide touch the lives of patients daily by training and educating them about insulin pump therapy and managing a life with Type 1 diabetes. It is this dedication and personal connection with patients that makes Animas such a fascinating place to work.
During my first few days at Animas, we received notification from our Quality Assurance team that certain lots of the 2-millimeter insulin cartridges provided to customers could leak insulin, which could cause under delivery of insulin to the patient.
Our team at Animas initiated a voluntary recall and put a plan into action that focused, first and foremost, on addressing the safety of patients who use our products. We were able to trace the affected cartridges to six specific lots and devised a plan to alert our customers.
We first sent an email on Feb. 22 to customers who received cartridges from the identified lots, advising them to discontinue use of those cartridges, and use other cartridges they have on hand or revert to their backup insulin administration plan as instructed by their health care providers until they received a replacement shipment of cartridges from Animas later that week.